{"id":888243,"date":"2026-06-24T00:04:19","date_gmt":"2026-06-24T00:04:19","guid":{"rendered":"https:\/\/www.europesays.com\/us\/888243\/"},"modified":"2026-06-24T00:04:19","modified_gmt":"2026-06-24T00:04:19","slug":"ups-is-investing-48-million-in-temperature-controlled-facilities-to-meet-glp-1-boom","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/888243\/","title":{"rendered":"UPS is investing $48 million in temperature-controlled facilities to meet GLP-1 boom"},"content":{"rendered":"<p><a aria-label=\"Go to https:\/\/fortune.com\/company\/ups\/\" href=\"https:\/\/fortune.com\/company\/ups\/\" target=\"_blank\" rel=\"nofollow noopener\">United Parcel Service<\/a> is investing $48 million into 27 temperature-controlled facilities as it continues its push into healthcare services, the freight company announced on Monday.<\/p>\n<p class=\"wp-block-paragraph\">The expansion of these global facilities, which are designed for short-term storage between air and ground transportation, allows UPS to better tap into an emerging <a aria-label=\"Go to https:\/\/growthmarketreports.com\/report\/cold-chain-logistics-for-biologics-market\" href=\"https:\/\/growthmarketreports.com\/report\/cold-chain-logistics-for-biologics-market\" rel=\"nofollow noopener\" target=\"_blank\">$39.1 billion temperature-sensitive biologics market<\/a>, which continues to grow amid ballooning demand for medication that is required to be stored cold.<\/p>\n<p class=\"wp-block-paragraph\">\u201cThis effort\u2014and all of our work in healthcare logistics\u2014extends from a deep understanding that we\u2019re doing more than moving packages,\u201d Kate Gutmann, executive vice president and president of international, healthcare and supply chain solutions at UPS, said in a <a aria-label=\"Go to https:\/\/about.ups.com\/us\/en\/newsroom\/press-releases\/customer-first\/ups-extends-complex-healthcare-logistics-lead-with--48-million-i.html\" href=\"https:\/\/about.ups.com\/us\/en\/newsroom\/press-releases\/customer-first\/ups-extends-complex-healthcare-logistics-lead-with--48-million-i.html\" rel=\"nofollow noopener\" target=\"_blank\">statement<\/a>. \u201cWe are helping patients access the medications and treatments they need.\u201d<\/p>\n<p class=\"wp-block-paragraph\">The risk associated with improperly stored medicines is high. According to the World Health Organization, temperature problems are responsible for <a aria-label=\"Go to https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/bf88e08d-273b-48df-93b7-a1d7cb9ac02a\/content\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/bf88e08d-273b-48df-93b7-a1d7cb9ac02a\/content\" rel=\"nofollow noopener\" target=\"_blank\">50% of global vaccine waste<\/a> and cost $35 billion per year. Among the medications needed to be stored in temperature-controlled units are gene and cell therapies, mRNA vaccines, and GLP-1 injectables.<\/p>\n<p class=\"wp-block-paragraph\">GLP-1s in particular have seen soaring popularity, with one in eight adults reporting using the medication to treat diabetes,weight loss, or another condition, according to <a aria-label=\"Go to https:\/\/www.kff.org\/public-opinion\/poll-1-in-8-adults-say-they-are-currently-taking-a-glp-1-drug-for-weight-loss-diabetes-or-another-condition-even-as-half-say-the-drugs-are-difficult-to-afford\/\" href=\"https:\/\/www.kff.org\/public-opinion\/poll-1-in-8-adults-say-they-are-currently-taking-a-glp-1-drug-for-weight-loss-diabetes-or-another-condition-even-as-half-say-the-drugs-are-difficult-to-afford\/\" rel=\"nofollow noopener\" target=\"_blank\">KFF data<\/a> from November 2025. Pharmaceutical companies have raced to meet the growing demand for the medication. Ely Lilly announced in March plans to <a aria-label=\"Go to https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/eli-lilly-invest-3-billion-china-over-next-decade-2026-03-11\/\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/eli-lilly-invest-3-billion-china-over-next-decade-2026-03-11\/\" rel=\"nofollow noopener\" target=\"_blank\">invest $3 billion<\/a> over the next decade into expanding manufacturing in China, primarily to increase production capacity for orforglipron, the company\u2019s experimental GLP-1 receptor.<\/p>\n<p class=\"wp-block-paragraph\">Demand for the drug is expected to grow. Starting July 1, Medicare beneficiaries may be able to get some GLP-1 prescriptions for $50 per month under a new <a aria-label=\"Go to https:\/\/www.cms.gov\/medicare\/coverage\/prescription-drug-coverage\/medicare-glp-1-bridge\" href=\"https:\/\/www.cms.gov\/medicare\/coverage\/prescription-drug-coverage\/medicare-glp-1-bridge\" rel=\"nofollow noopener\" target=\"_blank\">Centers for Medicare &amp; Medicaid Services initiative<\/a>.<\/p>\n<p><strong>Freight carriers\u2019 healthcare push<\/strong><\/p>\n<p class=\"wp-block-paragraph\">UPS\u2019s push into temperature-controlled facilities represents a growing trend of freight companies investing in healthcare logistics to protect themselves against economic uncertainties hitting demand elsewhere.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">Healthcare demand is often inelastic, meaning even in times of dire financial straits, people are still seeking treatment, and companies like UPS and <a aria-label=\"Go to https:\/\/fortune.com\/company\/fedex\/\" href=\"https:\/\/fortune.com\/company\/fedex\/\" target=\"_blank\" rel=\"nofollow noopener\">FedEx<\/a> are wanting to capitalize.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">\u201cThere have been lots of challenges over the past several years\u2014high \u200binflation, contractions in markets\u2014but healthcare continues to grow,\u201d UPS CEO Carol Tome <a aria-label=\"Go to https:\/\/www.reuters.com\/legal\/litigation\/ups-ceo-says-drug-delivery-strategy-good-antidote-economic-uncertainty-2026-04-30\/\" href=\"https:\/\/www.reuters.com\/legal\/litigation\/ups-ceo-says-drug-delivery-strategy-good-antidote-economic-uncertainty-2026-04-30\/\" rel=\"nofollow noopener\" target=\"_blank\">told Reuters<\/a> in April. \u201cI would argue that healthcare is pretty \u2060recession-proof.\u201d<\/p>\n<p class=\"wp-block-paragraph\">In January, UPS <a aria-label=\"Go to https:\/\/investors.ups.com\/news-events\/press-releases\/detail\/2133\/ups-completes-acquisitions-of-healthcare-cold-chain\" href=\"https:\/\/investors.ups.com\/news-events\/press-releases\/detail\/2133\/ups-completes-acquisitions-of-healthcare-cold-chain\" rel=\"nofollow noopener\" target=\"_blank\">acquired Frigo-Trans and BPL<\/a>, European healthcare logistic services companies for cold-chain transportation. The move followed the November 2025 <a aria-label=\"Go to https:\/\/about.ups.com\/sg\/en\/newsroom\/press-releases\/our-strategy\/ups-acquires-andlauer-healthcare-group-for--1-6-billion--acceler.html\" href=\"https:\/\/about.ups.com\/sg\/en\/newsroom\/press-releases\/our-strategy\/ups-acquires-andlauer-healthcare-group-for--1-6-billion--acceler.html\" rel=\"nofollow noopener\" target=\"_blank\">acquisition of Andlauer Healthcare Group<\/a> for $1.6 billion.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">The healthcare pivot appears to be paying off. Tome said during the company\u2019s <a aria-label=\"Go to https:\/\/investors.ups.com\/news-events\/ir-calendar\/detail\/10988\/q1-2026-united-parcel-service-inc-earnings-conference-call#register\" href=\"https:\/\/investors.ups.com\/news-events\/ir-calendar\/detail\/10988\/q1-2026-united-parcel-service-inc-earnings-conference-call#register\" rel=\"nofollow noopener\" target=\"_blank\">first-quarter earrings call<\/a> in April UPS\u2019s global healthcare portfolio has gained market share every year since 2021, generating $3 billion in revenue last quarter for the first time.<\/p>\n<p class=\"wp-block-paragraph\">FedEx is employing a similar strategy, <a aria-label=\"Go to https:\/\/seekingalpha.com\/article\/4769319-fedex-corporation-fdx-q3-2025-earnings-call-transcript\" href=\"https:\/\/seekingalpha.com\/article\/4769319-fedex-corporation-fdx-q3-2025-earnings-call-transcript\" rel=\"nofollow noopener\" target=\"_blank\">onboarding a healthcare-focused vice president of quality<\/a> with experience in global healthcare logistics earlier this year. FedEx ended the 2024 fiscal year with <a aria-label=\"Go to https:\/\/seekingalpha.com\/article\/4769319-fedex-corporation-fdx-q3-2025-earnings-call-transcript\" href=\"https:\/\/seekingalpha.com\/article\/4769319-fedex-corporation-fdx-q3-2025-earnings-call-transcript\" rel=\"nofollow noopener\" target=\"_blank\">about $9 billion in health care revenue<\/a>.<\/p>\n<p class=\"wp-block-paragraph\">\u201cTo attract new business in pharma, where we are currently under-penetrated, we are enhancing our offering to serve the specialized, unique needs of our customers with extreme emphasis on quality,\u201d FedEx Chief Customer Officer Brie Carere told investors in March.<\/p>\n","protected":false},"excerpt":{"rendered":"United Parcel Service is investing $48 million into 27 temperature-controlled facilities as it continues its push into healthcare&hellip;\n","protected":false},"author":3,"featured_media":888244,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[35],"tags":[13657,69952,26014,210,1141,1142,13660,67,132,54966,68],"class_list":["post-888243","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-fedex","tag-freight","tag-glp-1s","tag-health","tag-health-care","tag-healthcare","tag-logistics","tag-united-states","tag-unitedstates","tag-ups","tag-us"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116802162867150481","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/888243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=888243"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/888243\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/888244"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=888243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=888243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=888243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}